Physician profile
Adrian P Pay
NPI 1417041203
$8,601.74
in general payments reported to CMS, 2019-2025
40 companies · $1,083 in 2025
The $1,083 reported for 2025 was more than what 86% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,658 · 2020: $558 · 2021: $979 · 2022: $1,271 · 2023: $1,796 · 2024: $1,257 · 2025: $1,083.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,136.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,136.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,569.04 | 2019-2025 | Jardiance, Spiriva Respimat |
| Novo Nordisk INC | $818.46 | 2019-2025 | Wegovy, Ozempic, Rybelsus |
| Astrazeneca Pharmaceuticals LP | $695.94 | 2019-2024 | Farxiga, Fasenra, Airsupra |
| Pfizer INC. | $672.17 | 2019-2025 | |
| Glaxosmithkline, LLC. | $569.81 | 2019-2025 | Arexvy, Trelegy Ellipta |
| Lilly USA, LLC | $467.78 | 2019-2025 | Jardiance, Zepbound, Mounjaro |
| Eisai INC. | $346.04 | 2023-2025 | |
| Janssen Pharmaceuticals, INC | $319.86 | 2020-2023 | Spravato |
| E.R. Squibb & Sons, L.L.C. | $263.25 | 2020-2025 | Eliquis, Camzyos |
| Phathom Pharmaceuticals, INC. | $227.19 | 2024-2025 | Voquezna |
| Allergan, INC. | $225.36 | 2019-2020 | |
| Astellas Pharma US INC | $196.60 | 2020-2022 | |
| Mylan Specialty L.P. | $187.56 | 2019-2023 | Yupelri |
| Lundbeck LLC | $180.70 | 2023-2024 | Rexulti |
| Viiv Healthcare Company | $177.80 | 2022-2025 | Dovato |
Show all 40 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adrian Pay listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.